EXX5:XETRA:XETRA-iShares Dow Jones U.S. Select Dividend UCITS ETF (DE) EUR (EUR)

ETF | Others |

Last Closing

USD 80.32

Change

+0.44 (+0.55)%

Market Cap

USD 0.37B

Volume

0.01M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-29 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JARI:XETRA Amundi Index Solutions - Amund..

+0.33 (+0.73%)

USD 100.65B
EUNL:XETRA iShares Core MSCI World UCITS ..

+0.45 (+0.49%)

USD 84.07B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

+0.15 (+0.64%)

USD 79.79B
AW15:XETRA UBS (Irl) ETF plc - MSCI Japan..

+0.08 (+0.60%)

USD 58.88B
FJPR:XETRA Fidelity Sustainable Research ..

+0.03 (+0.48%)

USD 44.90B
EXX7:XETRA iShares Nikkei 225 UCITS ETF (..

+0.15 (+0.65%)

USD 28.25B
SPYL:XETRA SPDR S&P 500 UCITS ETF USD Acc..

+0.07 (+0.56%)

USD 23.49B
PPFB:XETRA iShares Physical Gold ETC EUR

-0.31 (-0.55%)

USD 20.66B
XDEE:XETRA Xtrackers S&P 500 Equal Weight..

+0.03 (+0.30%)

USD 12.74B
EUN5:XETRA iShares Core Corporate Bond UC..

-0.05 (-0.04%)

USD 12.26B

ETFs Containing EXX5:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -11.00% 22% F 23% F
Dividend Return -12.30% 56% F 24% F
Total Return -23.30% 7% C- 8% B-
Trailing 12 Months  
Capital Gain 0.77% 38% F 42% F
Dividend Return -12.58% 56% F 13% F
Total Return -11.81% 12% F 17% F
Trailing 5 Years  
Capital Gain 52.67% 56% F 59% D-
Dividend Return -5.02% 78% C+ 16% F
Total Return 47.65% 54% F 55% F
Average Annual (5 Year Horizon)  
Capital Gain 12.80% 77% C+ 75% C
Dividend Return 14.20% 82% B 79% B-
Total Return 1.41% 83% B 60% D-
Risk Return Profile  
Volatility (Standard Deviation) 17.54% 24% F 37% F
Risk Adjusted Return 80.99% 71% C- 74% C
Market Capitalization 0.37B 67% D+ 50% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.